Inhaltsbereich
| 16 Einträge |
Seite 1 / 1
 Druckansicht
|
| Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study. |
| Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Eberhardt WE, de Marinis F, Heeger S, Goddemeier T, O'Byrne KJ, Gatzemeier U |
| Lung cancer (Amsterdam, Netherlands). 2012 Apr 11. pii: S0169-5002(12)00121-3. doi: 10.1016/j.lungcan.2012.03.010 |
| PMID: 22498112 |
| EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. |
| Pirker R, Pereira JR, von Pawel J, Krzakowski M, Ramlau R, Park K, de Marinis F, Eberhardt WE, Paz-Ares L, Störkel S, Schumacher KM, von Heydebreck A, Celik I, O'Byrne KJ |
| The Lancet. Oncology. 2011 Nov 4. pii: S1470-2045(11)70318-7. doi: 10.1016/S1470-2045(11)70318-7 |
| PMID: 22056021 |
| Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. |
| Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold Ch, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2011 Sep 22. pii: mdr381. doi: 10.1093/annonc/mdr381 |
| PMID: 21940784 |
| Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. |
| Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U |
| Lancet (London, England). 2009 May 4. pii: S0140-6736(09)60569-9. doi: 10.1016/S0140-6736(09)60569-9 |
| PMID: 19410716 |
| Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. |
| Brodowicz T, Krzakowski M, Zwitter M, Tzekova V, Ramlau R, Ghilezan N, Ciuleanu T, Cucevic B, Gyurkovits K, Ulsperger E, Jassem J, Grgic M, Saip P, Szilasi M, Wiltschke C, Wagnerova M, Oskina N, Soldatenkova V, Zielinski C, Wenczl M |
| Lung cancer (Amsterdam, Netherlands). 2006 Mar 29. pii: S0169-5002(06)00060-2. doi: 10.1016/j.lungcan.2006.01.006 |
| PMID: 16569462 |
| Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC). |
| Belani CP, Brodowicz T, Ciuleanu T, Kim JH, Krzakowski M, Laack E, Wu YL, Peterson P, Krejcy K, Zielinski C |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.18_suppl.cra8000 |
| PMID: 27937591 |
| Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study. |
| Ciuleanu TE, Brodowicz T, Belani CP, Kim J, Krzakowski M, Laack E, Wu Y, Peterson P, Adachi S, Zielinski CC |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.8011 |
| PMID: 27949013 |
| FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). |
| Pirker R, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Park K, Gatzemeier U, Bajeta E, Emig M, Pereira JR |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.3 |
| PMID: 27948496 |
| Delay in time to worsening of symptoms (TWS) of advanced non-small cell lung cancer (NSCLC) using gemcitabine (gem) maintenance therapy. |
| Peterson P, Zwitter M, Krzakowski M, Wenczl M, Tzekova V, Ramlau R, Ciuleanu T, Liepa A, Zielinski C, Brodowicz T |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Jan 1. pii: 10.1200/jco.2006.24.18_suppl.7140 |
| PMID: 27953823 |
| Phase III study comparing cisplatin/vinorelbine plus cetuximab versus cisplatin/vinorelbine as first-line treatment for patients with epidermal growth factor (EGFR)-expressing advanced non-small cell lung cancer (NSCLC) (FLEX). |
| Von Pawel J, Park K, Pereira JR, Szczesna A, Yu C, Ganul VL, Krzakowski M, Roh JK, Pilz K, Pirker R |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Jan 1. pii: 10.1200/jco.2006.24.18_suppl.7109 |
| PMID: 27953547 |
| Time interval between final protocol approval (FPA) and inclusion of the first patient into randomized clinical trials (RCTs) performed by the Central European Cooperative Oncology Group (CECOG): A 10-year experience. |
| Brodowicz T, Steiner I, Beslija S, Ciuleanu TE, Inbar M, Krzakowski M, Kahan Z, Tzekova V, Vrbanec D, Zielinski CC |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 May 27. pii: 10.1200/jco.2009.27.15_suppl.6546 |
| PMID: 27964062 |
| Prognostic factors in advanced NSCLC: Experience from the FLEX trial. |
| Pirker R, Rodrigues-Pereira J, Szczesna A, Von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Emig M, Gatzemeier U |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.15_suppl.8083 |
| PMID: 27962658 |
| Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC). |
| Belani CP, Brodowicz T, Ciuleanu T, Kim JH, Krzakowski M, Laack E, Wu YL, Peterson P, Krejcy K, Zielinski C |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.15_suppl.cra8000 |
| PMID: 27962042 |
| First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. |
| Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV |
| The New England journal of medicine. 2018 Sep 25. doi: 10.1056/NEJMoa1809064 |
| PMID: 30280641 |
| Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. |
| Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold C, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)34677-0. doi: 10.1093/annonc/mdr381 |
| PMID: 32018580 |
| Brief Report: Exploratory analysis of maintenance therapy in patients with extensive-stage small cell lung cancer treated first-line with atezolizumab plus carboplatin and etoposide. |
| Reck M, Mok TSK, Mansfield A, De Boer R, Losonczy G, Sugawara S, Dziadziuszko R, Krzakowski M, Smolin A, Hochmair M, Garassino MC, de Castro Junior G, Bischoff H, Lam S, Cardona A, Morris S, Liu SV |
| Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2022 Jun 25. pii: S1556-0864(22)00300-8. doi: 10.1016/j.jtho.2022.05.016 |
| PMID: 35764236 |
| 16 Einträge |
Seite 1 / 1
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
